Mini-dose titration of the transdermal fentanyl patch - A novel approach by adjusting the area of absorption [4]

Journal of Pain and Symptom Management

Volumn 30, Issue 1, 2005, Pages 7-8

  Peng, Yu Ren ^a   Sun, Wei Zen ^a   Mok, Martin S ^b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; FENTANYL CITRATE; MORPHINE; OPIATE;

CONTROLLED DRUG RELEASE; DOSE CALCULATION; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG USE; LETTER; TITRIMETRY;

ABSORPTION; ADMINISTRATION, CUTANEOUS; ANALGESICS, OPIOID; DELAYED-ACTION PREPARATIONS; FENTANYL; HUMANS; PAIN; TITRIMETRY;

EID: 22544481165     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2005.05.002     Document Type: Letter

References (7)

1. S. Mercadante, P. Villari, and P. Ferrera Clinical problems with transdermal fentanyl titration from 25 to 50 μg/hr J Pain Symptom Manage 21 6 2001 448 449
2. Janssen Pharmaceutica. Full U.S. prescribing information of Duragesic. Janssen: Beerse, Belgium, 2000.
3. Janssen Pharmaceutica. Full U.S. prescribing information of Duragesic. Janssen: Beerse, Belgium, 2004.
4. J.J. Collins, I.J. Dunkel, and S.K. Gupta Transdermal fentanyl in children with cancer pain: feasibility, tolerability, and pharmacokinetic correlates J Pediatr 134 3 1999 319 323
5. A. Hunt, A. Goldman, and T. Devine Transdermal fentanyl for pain relief in a pediatric palliative care population Palliat Med 15 2001 405 412
6. W.E. Hardwick, W.D. King, and P.A. Palmissano Respiratory depression in a child unintentionally exposed to transdermal fentanyl patch South Med J 90 1997 962 964
7. Y.-R. Peng, and W.-Z. Sun A novel approach to produce mini-titration of Duragesic patch Acta Anaesthesiol Sinica 40 3 2002 S102